Atara Biotherapeutics Ownership | Who Owns Atara Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Atara Biotherapeutics Ownership Summary


Atara Biotherapeutics is owned by 31.73% institutional investors, 16.92% insiders, and 51.35% retail investors. Ecor1 capital is the largest institutional shareholder, holding 11.02% of ATRA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.05% of its assets in Atara Biotherapeutics shares.

ATRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtara Biotherapeutics31.73%16.92%51.35%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ecor1 capital1.55M11.02%$17.82M
Adage capital partners gp850.00K6.04%$9.76M
Point72 asset management687.72K4.88%$7.90M
Redmile group441.70K3.14%$5.07M
Vanguard capital management247.05K1.75%$2.84M
Vanguard group225.94K1.67%$4.09M
Mackenzie financial233.25K1.66%$2.68M
Blackrock funding, inc. /de84.45K0.60%$969.54K
Geode capital management75.13K0.53%$862.92K
Staley capital advisers50.00K0.36%$574.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ecor1 capital1.55M0.87%$17.82M
Redmile group441.70K0.34%$5.07M
Staley capital advisers50.00K0.02%$574.00K
Adage capital partners gp850.00K0.01%$9.76M
Point72 asset management687.72K0.01%$7.90M
Bridgeway capital management14.00K0.00%$160.72K
Mackenzie financial233.25K0.00%$2.68M
Xtx topco15.30K0.00%$175.68K
Acadian asset management38.84K0.00%$444.00K
Caitong asset management311.000.00%$3.57K

Top Buyers

HolderShares% AssetsChange
Ecor1 capital1.55M0.87%1.45M
Point72 asset management687.72K0.01%493.45K
Adage capital partners gp850.00K0.01%150.00K
Vanguard capital management247.05K0.00%29.18K
Vanguard group225.94K0.00%22.50K

Top Sellers

HolderShares% AssetsChange
Blackrock---6.83M
Bank of america corp /de/---6.58M
Price t rowe associates inc /md/---4.96M
Aqr capital management---2.63M
Woodline partners lp---1.77M

New Positions

HolderShares% AssetsChangeValue
Xtx topco15.30K0.00%15.30K$175.68K
Caitong asset management311.000.00%311.00$3.57K
Barclays304.00-304.00$3.49K

Sold Out

HolderChange
Western wealth management-1.00
Nelson, van denburg & campbell wealth management group-23.00
Eversource wealth advisors-35.00
Nisa investment advisors-50.00
Gamma investing-56.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026365.88%4,467,95474.24%319.57%16-5.88%8166.67%
Mar 31, 202633-21.43%2,564,23025.10%208.95%16-15.79%3-62.50%
Dec 31, 20257-81.08%379,045-79.87%21.17%3-81.25%1-85.71%
Sep 30, 20258-73.33%233,049-86.80%10.91%3-62.50%--100.00%
Jun 30, 202532-8.57%1,803,95019.18%147.48%11-8.33%6-53.85%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF120.26K2.05%-
Mackenzie Quantitative US Small Cap167.40K1.86%154.50K
Vanguard Total Stock Mkt Idx Inv158.65K1.76%-
Vanguard Morn Total Stk Mkt Idx Investor158.65K1.76%-
Vanguard Institutional Extnd Mkt Idx Tr82.76K0.92%24.54K
Mackenzie GQE US Small Cap F874.89K0.83%-27.63K
Fidelity Extended Market Index36.40K0.40%7.00K
Bridgeway Ultra-Small Company18.69K0.22%-
iShares Micro-Cap ETF17.00K0.19%-226.00
Fidelity Enhanced Small Cap ETF10.45K0.18%-

Recent Insider Transactions


DateNameRoleActivityValue
May 18, 2026Nguyen AnhCo President and CEOSell$47.84K
May 18, 2026Grant-Huerta Yanina Chief Accounting OfficerSell$22.04K
May 07, 2026Panacea Innovation Ltd-Sell$3.17M
May 07, 2026EcoR1 Capital, LLC-Buy$4.74M
Mar 02, 2026Grant-Huerta Yanina Chief Accounting OfficerSell$121.85

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q213
2026 Q1-9
2025 Q4-5
2025 Q326

ATRA Ownership FAQ


Who Owns Atara Biotherapeutics?

Atara Biotherapeutics shareholders are primarily institutional investors at 31.73%, followed by 16.92% insiders and 51.35% retail investors. The average institutional ownership in Atara Biotherapeutics's industry, Biotech Stocks , is 49.09%, which Atara Biotherapeutics falls below.

Who owns the most shares of Atara Biotherapeutics?

Atara Biotherapeutics’s largest shareholders are Ecor1 capital (1.55M shares, 11.02%), Adage capital partners gp (850K shares, 6.04%), and Point72 asset management (687.72K shares, 4.88%). Together, they hold 21.94% of Atara Biotherapeutics’s total shares outstanding.

Does Blackrock own Atara Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Atara Biotherapeutics.

Who is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Ecor1 capital is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.87% of its assets in 1.55M Atara Biotherapeutics shares, valued at 17.82M$.

Who is the top mutual fund holder of Atara Biotherapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Atara Biotherapeutics shares, with 2.05% of its total shares outstanding invested in 120.26K Atara Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools